Diagnostic and management considerations posed by multiple café au lait spots

Archives of Dermatology

Volumn 145, Issue 8, 2009, Pages 929-930

  Riccardi, Vincent M ^a  

^a Neurofibromatosis Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFE AU LAIT SPOT; DIFFERENTIAL DIAGNOSIS; DISABILITY; DYSPLASIA; EDITORIAL; GENE MUTATION; GENOTYPE; GLIOBLASTOMA; GLIOMA; HYPERPIGMENTATION; HYPERTRICHOSIS; LENTIGO; MACROCEPHALY; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NEUROFIBROMATOSIS; NEUROFIBROSARCOMA; NEUROIMAGING; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; SCOLIOSIS; SKELETON MALFORMATION; VISUAL SYSTEM;

BRAIN; CAFE-AU-LAIT SPOTS; DNA MUTATIONAL ANALYSIS; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROFIBROMATOSIS 1;

EID: 68949110066     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.180     Document Type: Editorial

References (12)

1. Nunley KS, Gao F, Albers AC, Bayliss SJ, Gutmann DH. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1. Arch Dermatol. 2009;145(8):883-887.
2. Riccardi VM. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. 2nd ed. Baltimore, MD: Johns Hopkins University Press; 1992.
3. Lammert M, Friedman JM, Kluwe L, Mautner V-F. Prevalence of Neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 2005;141(1):71-74.
4. Neurofibromatosis: conference statement: National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45(5):575-578.
5. Upadhyaya M, Huson SM, Davies M, et al. An absence of cutaneous neurofibromas associated with a 3-bp in-frame deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet. 2007;80(1):140-151.
6. Maertens O, De Schepper S, Vandesompele J, et al. Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet. 2007;81(2):243-251.
7. Kayes LM, Burke W, Riccardi VM, et al. Deletions spanning the neurofibromatosis 1 gene: Identification and phenotype of five patients. Am J Hum Genet. 1994;54(3):424-436.
8. Upadhyaya M, Kluwe L, Spurlock G, et al. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs). Hum Mutat. 2008;29(1):74-82.
9. Messiaen LM, Callens T, Mortier G, et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat. 2000;15(6):541-555.
10. Pasmant E, Sabbagh A, Hanna N, et al. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype [published online ahead of print April 14, 2009]. J Med Genet. doi:10.1136/jmg.2008.065243.
11. Arnsmeier SL, Riccardi VM, Paller AS. Familial multiple cafe au lait spots. Arch Dermatol. 1994;130(11):1425-1426.
12. Cai W, Kassarjian A, Bredella MA, et al. Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images. Radiology. 2009;250(3):665-673.